Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

被引：2
作者：
Zhu, Ling-ling [1 ]
Feng, Zhi-jun [2 ]
Zhou, Quan [3 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Geriatr VIP Ward,Div Nursing, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Urol, Hangzhou 310009, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pharm, Hangzhou 310009, Zhejiang, Peoples R China
来源：
CLINICAL INTERVENTIONS IN AGING | 2015年 / 10卷
关键词：
ALFUZOSIN; 10; MG; EFFICACY; SUBTYPE; SAFETY; SELECTIVITY; MANAGEMENT; SILODOSIN;
D O I：
10.2147/CIA.S82435
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：621 / 622
页数：2
相关论文
共 50 条
[21]   Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia [J].
Hwang, Eu Chang ;
Gandhi, Shreyas ;
Jung, Jae Hung ;
Imamura, Mari ;
Kim, Myung Ha ;
Pang, Ran ;
Dahm, Philipp .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10)
[22]   Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile [J].
Crawford, ED .
BJU INTERNATIONAL, 2005, 95 :1-5
[23]   Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015 [J].
Schauer, Ingrid ;
Madersbacher, Stephan .
CURRENT OPINION IN UROLOGY, 2015, 25 (01) :6-11
[24]   Factors Considered by Experienced Urologists when Selecting Alpha-Blockers for Patients with Lower Urinary Tract Symptoms or Benign Prostatic Hyperplasia according to Age [J].
Lee, Hyomyoung ;
Lee, Jung Hoon ;
Choo, Min Soo ;
Cho, Min Chul ;
Son, Hwancheol ;
Jeong, Hyeon ;
Yoo, Sangjun .
UROLOGIA INTERNATIONALIS, 2024, 108 (05) :434-441
[25]   α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies [J].
Fusco, Ferdinando ;
Palmieri, Alessandro ;
Ficarra, Vincenzo ;
Giannarini, Gianluca ;
Novara, Giacomo ;
Longo, Nicola ;
Verze, Paolo ;
Creta, Massimiliano ;
Mirone, Vincenzo .
EUROPEAN UROLOGY, 2016, 69 (06) :1091-1101
[26]   CLINICAL AND URODYNAMIC RESULTS OF ALPHA BLOCKER DRUG TREATMENT IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC HYPERPLASIA [J].
Salinas, J. .
ARCHIVOS ESPANOLES DE UROLOGIA, 2015, 68 (02) :161-171
[27]   Influence of alpha-adrenoceptor antagonists therapy on stool form in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia [J].
Matsumoto, Seiji ;
Kasamo, Sachiko ;
Hashizume, Kazumi .
LUTS-LOWER URINARY TRACT SYMPTOMS, 2020, 12 (01) :86-91
[28]   The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis [J].
Lee, Shaun Wen Huey ;
Chan, Esther Mei Ching ;
Lai, Yin Key .
SCIENTIFIC REPORTS, 2017, 7
[29]   Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia) [J].
Buzelin, JM ;
Fonteyne, E ;
Kontturi, M ;
Witjes, WPJ ;
Khan, A .
BRITISH JOURNAL OF UROLOGY, 1997, 80 (04) :597-605
[30]   Long-term treatment and prognostic factors of α1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: A pilot study comparing naftopidil and tamsulosin hydrochloride [J].
Kawachi, Yoshio ;
Sakurai, Toru ;
Sugimura, Sosuke ;
Iwata, Shinji ;
Noto, Kensho ;
Honda, Shin-Ichi ;
Maruyama, Osamu .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2010, 44 (01) :38-45
12345